Carlos Velez-Pardo Selected Research

5,6-Dihydroxytryptamine (5,6 Dihydroxytryptamine)

2/2002

Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Velez-Pardo Research Topics

Disease

13	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 08/2001
10	Leukemia 09/2022 - 06/2011
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 06/2011
9	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2011
7	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 02/2002
6	Neoplasms (Cancer) 01/2018 - 06/2011
5	Parkinsonian Disorders (Parkinsonism) 10/2021 - 03/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 01/2017
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 01/2016
2	Amyloid Plaque 01/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2008 - 03/2004
1	Nervous System Diseases (Neurological Disorders) 10/2021
1	Memory Disorders (Memory Loss) 01/2020
1	Neuroblastoma 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Adenocarcinoma 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2015
1	Heart Diseases (Heart Disease) 03/2015
1	Dyslipidemias (Dyslipidemia) 03/2015
1	Starvation 01/2013
1	Dementia (Dementias) 12/2012
1	Movement Disorders (Movement Disorder) 06/2011
1	Hepatolenticular Degeneration (Wilson's Disease) 09/2004
1	Hippocampal Sclerosis 07/2004
1	Epilepsy (Aura) 07/2004
1	Seizures (Absence Seizure) 07/2004

Drug/Important Bio-Agent (IBA)

7	Caspase 3 (Caspase-3)IBA 09/2022 - 03/2004
5	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 05/2022 - 01/2012
4	tocophersolanIBA 05/2022 - 01/2016
4	Cholinergic Agents (Cholinergics)IBA 12/2021 - 01/2019
4	IronIBA 05/2017 - 03/2004
4	Presenilin-1IBA 01/2015 - 08/2001
4	PolyphenolsIBA 01/2015 - 06/2011
3	tau Proteins (tau Protein)IBA 12/2021 - 01/2020
3	Neuroprotective AgentsIBA 10/2021 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 02/2008
3	Chelating AgentsIBA 01/2018 - 01/2012
3	MetalsIBA 01/2018 - 12/2011
3	ParaquatIBA 05/2017 - 01/2013
3	Leucine (L-Leucine)FDA Link 01/2017 - 10/2016
3	Phosphotransferases (Kinase)IBA 01/2017 - 10/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 06/2011
2	Amyloid (Amyloid Fibrils)IBA 12/2021 - 01/2021
2	AntioxidantsIBA 10/2021 - 01/2013
2	CannabinoidsIBA 01/2021 - 01/2020
2	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 01/2021 - 01/2020
2	Snake Venoms (Snake Venom)IBA 08/2019 - 09/2016
2	Minocycline (Cyclops)FDA LinkGeneric 01/2018 - 05/2017
2	Vitamin E FDA LinkGeneric 01/2018 - 01/2016
2	ZincIBA 01/2018 - 01/2012
2	RotenoneIBA 11/2016 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 01/2014
2	Apoptosis Inducing FactorIBA 09/2016 - 01/2013
2	Apolipoproteins E (ApoE)IBA 03/2015 - 12/2012
2	CopperIBA 12/2011 - 09/2004
2	Flavin-Adenine Dinucleotide (FAD)IBA 07/2004 - 08/2001
1	Peptides (Polypeptides)IBA 09/2022
1	Cell-Penetrating PeptidesIBA 09/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Amyloid beta-PeptidesIBA 11/2019
1	L-Amino Acid OxidaseIBA 08/2019
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2019
1	Succinic Acid (Succinate)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	LipidsIBA 01/2018
1	diazonaphthalenedisulfonic acid (NDS)IBA 09/2017
1	bcr-abl Fusion ProteinsIBA 01/2017
1	Codon (Codons)IBA 01/2017
1	FructoseIBA 11/2016
1	3- (4- (morpholin- 4- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 5- yl)benzonitrileIBA 10/2016
1	Metalloproteases (Metalloproteinases)IBA 09/2016
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	Gallic AcidIBA 12/2013
1	ApolipoproteinsIBA 12/2012
1	Biomarkers (Surrogate Marker)IBA 12/2012
1	ManganeseIBA 12/2011
1	IonsIBA 12/2011
1	Trace Elements (Biometals)IBA 12/2011
1	VitaminsIBA 06/2011
1	Peptide Hydrolases (Proteases)FDA Link 06/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2011
1	Superoxides (Superoxide)IBA 06/2011
1	Vitamin K 3 (Menadione)FDA Link 06/2011
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2011
1	Insulin-Like PeptidesIBA 03/2006
1	P-type ATPasesIBA 09/2004
1	Dopamine (Intropin)FDA LinkGeneric 03/2004
1	NF-kappa B (NF-kB)IBA 03/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2004
1	Hydroxyl RadicalIBA 03/2004
1	5,6-Dihydroxytryptamine (5,6 Dihydroxytryptamine)IBA 02/2002
1	5,7-Dihydroxytryptamine (5,7 Dihydroxytryptamine)IBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2014 - 06/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 06/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021
1	Aftercare (After-Treatment) 01/2018
1	Radiotherapy 06/2011